KEYWORD INDEX

Click on the first letter of the keyword:
 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Search results for: "S"
Results 1 - 10 of 344 shown below
S-100beta
Kimberly Bell, David Shokrian, Carl Potenzieri and Patricia M Whitaker-Azmitia
Harm Avoidance, Anxiety, and Response to Novelty in the Adolescent S-100beta Transgenic Mouse: Role of Serotonin and Relevance to Down Syndrome
doi:10.1038/sj.npp.1300242
Neuropsychopharmacology 28, 1840-1845

Abstract | Full text | PDF |
S-ketamine
Euphrosyne Gouzoulis-Mayfrank, Karsten Heekeren, Anna Neukirch, Martina Stoll, Carsten Stock, Joerg Daumann, Maja Obradovic and Karl-Artur Kovar
Inhibition of Return in the Human 5HT2A Agonist and NMDA Antagonist Model of Psychosis
doi:10.1038/sj.npp.1300882
Neuropsychopharmacology 31, 431-441

Abstract | Full text | PDF |
S–mephenytoin 4–hydroxylation
Koichi Otani, Norio Yasui, Sunao Kaneko, Tadashi Ohkubo, Takako Osanai, Kazunobu Sugawara, Kunihiko Hayashi, Kan Chiba and Takashi Ishizaki
Effects of Genetically Determined S–Mephenytoin 4–Hydroxylation Status and Cigarette Smoking on the Single–Dose Pharmacokinetics of Oral Alprazolam
doi:10.1016/S0893-133X(96)00165-0
Neuropsychopharmacology 16, 8-14

Abstract | PDF |
S100 proteins
Matthias Rothermundt, Gerald Ponath, Thomas Glaser, Guenter Hetzel and Volker Arolt
S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia
doi:10.1038/sj.npp.1300403
Neuropsychopharmacology 29, 1004-1011

Abstract | Full text | PDF |
S[+]-N-n-propylnorapomorphine
Frank I Tarazi, Sylva K Yeghiayan, Ross J Baldessarini, Nora S Kula and John L Neumeyer
Long-Term Effects of S(+)N-n-Propylnorapomorphine Compared with Typical and Atypical Antipsychotics: Differential Increases of Cerebrocortical D2-Like and Striatolimbic D4-Like Dopamine Receptors
doi:10.1016/S0893-133X(97)00046-8
Neuropsychopharmacology 17, 186-196

Abstract | PDF |
saccade
Sheree Cairney, Alan R Clough, Paul Maruff, Alex Collie, Bart J Currie and Jon Currie
Saccade and Cognitive Function in Chronic Kava Users
doi:10.1038/sj.npp.1300052
Neuropsychopharmacology 28, 389-396

Abstract | Full text | PDF |
Saccades
Deborah S Cowley, Peter P Roy-Byrne, Allen Radant, James C Ritchie, David J Greenblatt, Charles B Nemeroff and Daniel W Hommer
Benzodiazepine Sensitivity in Panic Disorder: Effects of Chronic Alprazolam Treatment
doi:10.1016/0893-133X(94)00074-A
Neuropsychopharmacology 12, 147-157

Abstract | PDF |
John A Sweeney, Kenneth S Bauer, Matcheri S Keshavan, Gretchen L Haas, Nina R Schooler and Patricia D Kroboth
Adverse Effects of Risperidone on Eye Movement Activity: A Comparison of Risperidone and Haloperidol in Antipsychotic-Naive Schizophrenic Patients
doi:10.1016/S0893-133X(96)00195-9
Neuropsychopharmacology 16, 217-228

Abstract | PDF |
Ann Olincy, Randal G Ross, David A Young, Margaret Roath and Robert Freedman
Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients
doi:10.1016/S0893-133X(97)00095-X
Neuropsychopharmacology 18, 175-185

Abstract | PDF |
Saccadic eye velocity
Inger Sundströ, Sigrid Nyberg and Torbjörn Bäckström
Patients with Premenstrual Syndrome Have Reduced Sensitivity to Midazolam Compared to Control Subjects
doi:10.1016/S0893-133X(97)00086-9
Neuropsychopharmacology 17, 370-381

Abstract | PDF |
saccharin
Jennifer Lynn Short, Catherine Ledent, John Drago and Andrew John Lawrence
Receptor Crosstalk: Characterization of Mice Deficient in Dopamine D1 and Adenosine A2A Receptors
doi:10.1038/sj.npp.1300852
Neuropsychopharmacology 31, 525-534

Abstract | Full text | PDF |
safety
Sheena A Josselyn, William A Falls, Jonathan C Gewirtz, Paul Pistell and Michael Davis
The Nucleus Accumbens is not Critically Involved in Mediating the Effects of a Safety Signal on Behavior
doi:10.1038/sj.npp.1300530
Neuropsychopharmacology 30, 17-26

Abstract | Full text | PDF |
Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | | Next next
  top go to top

Extra navigation

.
ADVERTISEMENT